{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:35:17Z","timestamp":1773934517534,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016016","name":"Gilead UK and Ireland Corporate Contributions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["NCT05140941"],"award-info":[{"award-number":["NCT05140941"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJOG Global Reports"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.xagr.2025.100580","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:53:55Z","timestamp":1761130435000},"page":"100580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Care strategies for pregnant people and women living with hepatitis C in North America"],"prefix":"10.1016","volume":"6","author":[{"given":"Sofia R.","family":"Bartlett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmin E.","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Kushner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xagr.2025.100580_bib0001","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12029-017-9959-0","article-title":"Global epidemiology of hepatocellular carcinoma (HCC epidemiology)","volume":"48","author":"Ozakyol","year":"2017","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.xagr.2025.100580_bib0002","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","article-title":"Extrahepatic manifestations of chronic hepatitis C","volume":"42","author":"Cacoub","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.xagr.2025.100580_bib0003","doi-asserted-by":"crossref","first-page":"172","DOI":"10.14218\/JCTH.2018.00049","article-title":"HCV extrahepatic manifestations","volume":"7","author":"Kuna","year":"2019","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.xagr.2025.100580_bib0004","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.dld.2014.10.005","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"46","author":"Cacoub","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.xagr.2025.100580_bib0006","doi-asserted-by":"crossref","first-page":"540","DOI":"10.14745\/ccdr.v48i1112a07","article-title":"National hepatitis C estimates: incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019","volume":"48","author":"Popovic","year":"2022","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.xagr.2025.100580_bib0007","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/HEP.0000000000000927","article-title":"Estimating hepatitis C prevalence in the United States, 2017-2020","volume":"81","author":"Hall","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.xagr.2025.100580_bib0008","unstructured":"US Department of Health Human Services. Viral hepatitis national strategic plan: a roadmap to elimination for the United States, 2021-2025. Accessed Nov. 13, 2025.https:\/\/www.hhs.gov\/sites\/default\/files\/Viral-Hepatitis-National-Strategic-Plan-2021-2025.pdf"},{"key":"10.1016\/j.xagr.2025.100580_bib0009","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. Accessed Nov. 13, 2025. https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06"},{"key":"10.1016\/j.xagr.2025.100580_bib0010","unstructured":"Public Health Agency of Canada. Government of Canada's Sexually Transmitted and Blood-Borne Infections (STBBI) action plan 2024-2030. Accessed Nov. 13, 2025.https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/sexually-transmitted-blood-borne-infections-action-plan-2024-2030.html"},{"key":"10.1016\/j.xagr.2025.100580_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103654","article-title":"A gender lens is needed in hepatitis C elimination research","volume":"103","author":"Larney","year":"2022","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.xagr.2025.100580_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102596","article-title":"Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis","volume":"72","author":"Levinsson","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.xagr.2025.100580_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12905-021-01470-7","article-title":"Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study","volume":"21","author":"Pearce","year":"2021","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.xagr.2025.100580_bib0014","unstructured":"Public Health Agency of Canada. Hepatitis C in Canada: 2020 Surveillance Data Update. Accessed Nov. 13, 2025.https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/hepatitis-c-canada-2020-surveillance-data-update.html"},{"key":"10.1016\/j.xagr.2025.100580_bib0015","unstructured":"Centers for Disease Control and Prevention (CDC). Rates of reported cases of acute hepatitis, by sex\u2014United States, 2007-2022. Accessed Nov. 13, 2025.https:\/\/www.cdc.gov\/hepatitis-surveillance-2022\/hepatitis-c\/figure-3-5.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/hepatitis\/statistics\/2022surveillance\/hepatitis-c\/figure-3.5.htm"},{"key":"10.1016\/j.xagr.2025.100580_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.24770","article-title":"Trends in the prevalence of hepatitis C infection during pregnancy and maternal-infant outcomes in the US, 1998 to 2018","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.xagr.2025.100580_bib0017","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/jvh.12628","article-title":"Higher incidence of HCV in females compared to males who inject drugs: a systematic review and meta-analysis","volume":"24","author":"Esmaeili","year":"2017","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.xagr.2025.100580_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004988","article-title":"Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort","volume":"4","author":"Tracy","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.xagr.2025.100580_bib0019","article-title":"\u201cIf you're strung out and female, they will take advantage of you\u201d: a qualitative study exploring drug use and substance use service experiences among women in Boston and San Francisco","volume":"157","author":"Harris","year":"2024","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.xagr.2025.100580_bib0020","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2022.05.016","article-title":"Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmission","volume":"77","author":"Kushner","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.xagr.2025.100580_bib0021","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijid.2021.07.019","article-title":"Prospective cohort study of children exposed to hepatitis C virus through a pregnancy screening program","volume":"110","author":"Pinto","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.xagr.2025.100580_bib0022","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis","volume":"59","author":"Benova","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xagr.2025.100580_bib0023","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1055\/s-0040-1709185","article-title":"Hepatitis C virus infection in children and pregnant women: an updated review of the literature on screening and treatments","volume":"10","author":"Ragusa","year":"2020","journal-title":"Am J Perinatol Rep"},{"key":"10.1016\/j.xagr.2025.100580_bib0024","doi-asserted-by":"crossref","first-page":"313","DOI":"10.17219\/acem\/76739","article-title":"Hepatitis C infection among pregnant women in central Poland: significance of epidemiological anamnesis and impact of screening tests to detect infection","volume":"28","author":"Aniszewska","year":"2019","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.xagr.2025.100580_bib0026","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2018.11.013","article-title":"Epidemiology and natural history of hepatitis C virus infection among children and young people","volume":"70","author":"Modin","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.xagr.2025.100580_bib0027","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review","volume":"166","author":"Falade-Nwulia","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.xagr.2025.100580_bib0028","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/cid\/ciaa144","article-title":"Evaluation of sustained virologic response as a relevant surrogate endpoint for long-term outcomes of hepatitis C virus infection","volume":"72","author":"Krassenburg","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xagr.2025.100580_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.09.012","article-title":"Real-world effectiveness of direct-acting antiviral regimens against hepatitis C virus (HCV) genotype 3 infection: a systematic review and meta-analysis","volume":"23","author":"Zhuang","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.xagr.2025.100580_bib0030","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/ciad411","article-title":"Estimated prevalence and awareness of hepatitis C virus infection among US adults: national health and nutrition examination survey, January 2017\u2013March 2020","volume":"77","author":"Lewis","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xagr.2025.100580_bib0031","unstructured":"Centers for Disease Control and Prevention (CDC). Too few people treated for hepatitis C: reducing barriers can increase treatment and save lives. Updated Sep. 21, 2022. Accessed Nov. 13, 2025. https:\/\/www.cdc.gov\/vitalsigns\/hepc-treatment\/index.html"},{"key":"10.1016\/j.xagr.2025.100580_bib0032","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/02791072.2022.2129886","article-title":"Social networks, stigma, and hepatitis C care among women who inject drugs: findings from a community recruited sample","volume":"55","author":"Jones","year":"2023","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.xagr.2025.100580_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108684","article-title":"Health care-seeking experiences for people who inject drugs with hepatitis C: qualitative explorations of stigma","volume":"137","author":"Austin","year":"2022","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.xagr.2025.100580_bib0034","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.xagr.2025.100580_bib0035","doi-asserted-by":"crossref","first-page":"B8","DOI":"10.1016\/j.ajog.2021.06.008","article-title":"Society for Maternal-Fetal Medicine. Society for Maternal-Fetal Medicine consult series #56: hepatitis C in pregnancy\u2014updated guidelines","volume":"225","author":"Dotters-Katz","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2025.100580_bib0036","unstructured":"Sofosbuvir\/velpatasvir treatment of chronic hepatitis C during pregnancy (STORC). Accessed Nov. 13, 2025.https:\/\/clinicaltrials.gov\/study\/NCT05140941?term=sTORC&rank=1"},{"key":"10.1016\/j.xagr.2025.100580_bib0037","unstructured":"Feasibility and acceptability of HCV treatment in pregnancy. Accessed Nov. 13, 2025.https:\/\/clinicaltrials.gov\/study\/NCT06367465?term=pregnancy&cond=HCV&intr=Glecaprevir%2Fpibrentasvir&rank=1"},{"key":"10.1016\/j.xagr.2025.100580_bib0038","unstructured":"The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. HCV in Pregnancy. Updated 2023. Accessed Nov. 13, 2025. https:\/\/www.hcvguidelines.org\/unique-populations\/pregnancy"},{"key":"10.1016\/j.xagr.2025.100580_bib0039","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1055\/s-0041-1728827","article-title":"Pragmatic experience with risk-based versus universal hepatitis C screening in pregnancy: detection of infection and postpartum linkage to care","volume":"38","author":"Bushman","year":"2021","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.xagr.2025.100580_bib0040","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/hep4.1748","article-title":"Enhancing linkage to hepatitis C virus treatment following pregnancy in women identified during perinatal care","volume":"5","author":"Epstein","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.xagr.2025.100580_bib0041","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/08897077.2015.1118720","article-title":"Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: a retrospective cohort study","volume":"37","author":"Krans","year":"2016","journal-title":"Subst Abus"},{"key":"10.1016\/j.xagr.2025.100580_bib0042","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/jvh.13574","article-title":"Global cascade of care for chronic hepatitis C virus infection: a systematic review and meta-analysis","volume":"28","author":"Yousafzai","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.xagr.2025.100580_bib0043","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jhep.2023.05.044","article-title":"Evaluation and comparison of risk-based and universal prenatal HCV screening programs in Alberta","volume":"79","author":"Thompson","year":"2023","journal-title":"Canada J Hepatol"},{"key":"10.1016\/j.xagr.2025.100580_bib0044","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.amepre.2018.05.029","article-title":"Hepatitis C virus in women of childbearing age, pregnant women, and children","volume":"55","author":"Schillie","year":"2018","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.xagr.2025.100580_bib0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S2468-1253(20)30359-9","article-title":"Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study","volume":"6","author":"Dugan","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.xagr.2025.100580_bib0046","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jhep.2020.11.027","article-title":"Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy","volume":"74","author":"Kushner","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.xagr.2025.100580_bib0047","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0168-8278(99)80383-3","article-title":"Mother-to-infant transmission of hepatitis C virus","volume":"31","author":"Zanetti","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.xagr.2025.100580_bib0048","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2017.07.039","article-title":"Hepatitis C in pregnancy: screening, treatment, and management","volume":"217","author":"Hughes","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2025.100580_bib0049","doi-asserted-by":"crossref","first-page":"E594","DOI":"10.1503\/cmaj.161521","article-title":"Canadian Task Force on Preventive Health Care. Recommendations on hepatitis C screening for adults","volume":"189","year":"2017","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.xagr.2025.100580_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244575","article-title":"Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008\u20132019","volume":"15","author":"Pearce","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.xagr.2025.100580_bib0051","doi-asserted-by":"crossref","first-page":"ofy043","DOI":"10.1093\/ofid\/ofy043","article-title":"Risk-based hepatitis C screening in pregnancy is less reliable than universal screening: a retrospective chart review","volume":"5","author":"Boudova","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.xagr.2025.100580_bib0052","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8654741","article-title":"Risk-based prenatal hepatitis C testing practices and results, Alaska 2013-2016","volume":"2019","author":"Nolen","year":"2019","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.xagr.2025.100580_bib0053","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/AOG.0000000000005300","article-title":"Viral hepatitis in pregnancy: ACOG clinical practice guideline no. 6","volume":"142","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2025.100580_bib0054","first-page":"97","article-title":"HCV reflex testing: a single-sample, low-contamination method that improves the diagnostic efficiency of HCV testing among patients in Alberta, Canada","volume":"7","author":"Thompson","year":"2022","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.xagr.2025.100580_bib0055","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.clinthera.2018.05.010","article-title":"Hepatitis C management simplification from test to cure: a framework for primary care providers","volume":"40","author":"Kapadia","year":"2018","journal-title":"Clin Ther"},{"key":"10.1016\/j.xagr.2025.100580_bib0056","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series\u2606","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.xagr.2025.100580_bib0057","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/AOG.0000000000004822","article-title":"Hepatitis C virus testing during pregnancy after universal screening recommendations","volume":"140","author":"Kaufman","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2025.100580_bib0058","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jogc.2017.04.007","article-title":"No. 96-The reproductive care of women living with hepatitis C infection","volume":"39","author":"Boucher","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.xagr.2025.100580_bib0059","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.drugpo.2015.01.005","article-title":"Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: the ETHOS study","volume":"26","author":"Treloar","year":"2015","journal-title":"Australia Int J Drug Policy"},{"key":"10.1016\/j.xagr.2025.100580_bib0060","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.drugpo.2013.05.018","article-title":"It gives me a sense of belonging\u201d: providing integrated health care and treatment to people with HCV engaged in a psycho-educational support group","volume":"24","author":"Woolhouse","year":"2013","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.xagr.2025.100580_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.103019","article-title":"Perceptions of network based recruitment for hepatitis C testing and treatment among persons who inject drugs: a qualitative exploration","volume":"88","author":"Ward","year":"2021","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.xagr.2025.100580_bib0062","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/dar.13713","article-title":"Increasing linkage to hepatitis C care following trauma-informed rehabilitation: an education and quality improvement project among women","volume":"43","author":"Crespi","year":"2023","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.xagr.2025.100580_bib0063","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/SGA.0000000000000458","article-title":"Achieving hepatitis C elimination by using person-centered, nurse-led models of care: a discussion of four international case studies","volume":"43","author":"Richmond","year":"2020","journal-title":"Gastroenterol Nurs"},{"key":"10.1016\/j.xagr.2025.100580_bib0064","doi-asserted-by":"crossref","first-page":"ofad027","DOI":"10.1093\/ofid\/ofad027","article-title":"Modeling-based response-guided hepatitis C treatment during pregnancy and postpartum","volume":"10","author":"Kushner","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.xagr.2025.100580_bib0065","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/hep4.1264","article-title":"Evaluating women\u2019s preferences for hepatitis C treatment during pregnancy","volume":"2","author":"Kushner","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.xagr.2025.100580_bib0066","doi-asserted-by":"crossref","first-page":"S322","DOI":"10.1093\/infdis\/jiz659","article-title":"Hepatitis C virus incidence in a cohort in medication-assisted treatment for opioid use disorder in New York City","volume":"222","author":"Jordan","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.xagr.2025.100580_bib0067","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012021","article-title":"Effectiveness of needle\/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs","volume":"2016","author":"Platt","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xagr.2025.100580_bib0068","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence","volume":"106","author":"Turner","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.xagr.2025.100580_bib0069","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/add.12682","article-title":"The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users","volume":"109","author":"Nolan","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.xagr.2025.100580_bib0070","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ajog.2019.10.058","article-title":"Postpartum treatment for chronic hepatitis C virus among women in medication-assisted treatment for opioid use disorder: the potential of an integrated medical home model","volume":"221","author":"Laird","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2025.100580_bib0071","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/08897077.2015.1129388","article-title":"Project ECHO (Extension for Community Healthcare Outcomes): A new model for educating primary care providers about treatment of substance use disorders","volume":"37","author":"Komaromy","year":"2016","journal-title":"Substance abuse"},{"key":"10.1016\/j.xagr.2025.100580_bib0072","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1053\/j.gastro.2022.07.017","article-title":"Treatment of women with hepatitis C diagnosed in pregnancy: a co-located treatment approach","volume":"163","author":"Kushner","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xagr.2025.100580_bib0073","unstructured":"You Matter. Test, Link, Call (TLC) Project. Accessed Nov. 13, 2025. https:\/\/stbbipathways.ca\/test-link-call-project\/"},{"key":"10.1016\/j.xagr.2025.100580_bib0074","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12889-023-17524-4","article-title":"Shared experience makes this all possible\u201d: documenting the guiding principles of peer-led services for people released from prison","volume":"24","author":"Palis","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.xagr.2025.100580_bib0075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1108\/IJPH-09-2020-0069","article-title":"Supporting people leaving prisons during COVID-19: perspectives from peer health mentors","volume":"17","author":"McLeod","year":"2021","journal-title":"Int J Prison Health"},{"key":"10.1016\/j.xagr.2025.100580_bib0076","unstructured":"Unlocking The Gates Services Society. Unlocking the gates services society. Accessed Nov. 13, 2025. https:\/\/unlockingthegates.org\/"},{"key":"10.1016\/j.xagr.2025.100580_bib0077","unstructured":"You Matter. Impact evaluation report: test link call project. Accessed Nov. 13, 2025.https:\/\/stbbipathways.ca\/wp-content\/uploads\/2023\/11\/TLC-evaluation-report_2023-HD.pdf"},{"key":"10.1016\/j.xagr.2025.100580_bib0078","unstructured":"Centers for Disease Control and Prevention (CDC). Number of reported cases of acute Hepatitis C virus infection and estimated infections\u2014United States, 2014-2021. Updated 2023. Accessed Nov. 13, 2025.https:\/\/www.cdc.gov\/hepatitis-surveillance-2021\/hepatitis-c\/figure-3-1.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/hepatitis\/statistics\/2021surveillance\/hepatitis-c\/figure-3.1.htm"},{"key":"10.1016\/j.xagr.2025.100580_bib0079","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/medethics-2019-105692","article-title":"Respect women, promote health and reduce stigma: ethical arguments for universal hepatitis C screening in pregnancy","volume":"46","author":"Gross","year":"2020","journal-title":"J Med Ethics"},{"key":"10.1016\/j.xagr.2025.100580_bib0080","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s10900-014-9932-9","article-title":"Strategies for hepatitis C testing and linkage to care for vulnerable populations: point-of-care and standard HCV testing in a mobile medical clinic","volume":"39","author":"Morano","year":"2014","journal-title":"J Comm Health"},{"key":"10.1016\/j.xagr.2025.100580_bib0081","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/idr14010001","article-title":"Reported barriers to hepatitis C treatment among pregnant and early-parenting mothers undergoing substance use disorder treatment in one US state","volume":"14","author":"Adekunle","year":"2021","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.xagr.2025.100580_bib0082","doi-asserted-by":"crossref","first-page":"ofac157","DOI":"10.1093\/ofid\/ofac157","article-title":"Modeling-based response-guided DAA therapy for chronic hepatitis C to identify individuals for shortening treatment duration","volume":"9","author":"Goyal","year":"2022","journal-title":"Open Forum Infect Dis"}],"container-title":["AJOG Global Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577825001418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577825001418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:20:59Z","timestamp":1773926459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666577825001418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2666577825001418"],"URL":"https:\/\/doi.org\/10.1016\/j.xagr.2025.100580","relation":{},"ISSN":["2666-5778"],"issn-type":[{"value":"2666-5778","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Care strategies for pregnant people and women living with hepatitis C in North America","name":"articletitle","label":"Article Title"},{"value":"AJOG Global Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xagr.2025.100580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100580"}}